Newsletter Subject

Americans Less Confident in Vaccine System, Survey Finds

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, May 22, 2018 02:34 PM

Email Preheader Text

Rx Adherence Monitors Do Work... Mostly Daily Headlines May 22, 2018 Recent Headlines ADVERTISEMENT

Rx Adherence Monitors Do Work... Mostly Daily Headlines May 22, 2018 [Americans Less Confident in Vaccine System, Survey Finds]( [Rx Adherence Monitors Do Work... Mostly]( [Uninsured Rate Stays Flat at Nearly 30 Million]( [Eggs Are Good for the Heart... or Not]( [A Dearth of Residency Options: HealthLeaders Media]( Recent Headlines [Improving Healthcare Awareness]( [10 Questions to Challenge Your Medical News Savvy]( [Highlights of New Arthritis Pain Guidelines]( [Early Use of Burosumab Eases XLH Symptoms in Kids]( [Smoking and Parenting; Afib and Stroke: It's PodMed Double T!]( ADVERTISEMENT This Week's Survey [Is Acupuncture Just a Sham?]( [Another]([sham-controlled study of acupuncture]( -- this one involving in vitro fertilization -- didn't show an effect distinct from other aspects of the experience, such as the relaxing environment and the therapist's touch. CME Spotlights [Hematology CLL @POC]( [Source: @Point of Care]( [Immuno-Oncology @Point of Care]( [Immuno-Oncology @Point of Care, support clinical decision tool for cancer diagnosis, Tx & management]( [Hepatocellular Carcinoma @Point of Care]( [Hepatocellular Carcinoma @Point of Care, clinical decision support tool for HCC diagnosis, treatment & management]( [Head and Neck Cancer @Point of Care]( [Head and Neck Cancer @Point of Care, clinical decision support tool for head and neck cancer diagnosis, treatment & management. Source: @Point of Care]( [Breast Cancer @Point of Care]( [clinical decision support tool for breast cancer diagnosis, Tx & management]( More of Today's Stories [CPAP Lowered Heart Rate in Prediabetics with Sleep Apnea]( [Hypogonadal Men See Better Heart Health on Testosterone Tx]( [Trials Support Emicizumab as Standard Tx in Hemophilia A]( [Biologic Improves Severe Asthma Outcomes]( [Zika Worsens Short-Term Guillain-Barre Course]( [New Bupe Spray Gets Lukewarm Review from FDA]( [Pelvic RT Remains Standard of Care for High-Risk, Early-Stage Endometrial Cancer]( [FeNO Helps in Cough Treatment]( [Slow Medicine: Preventing Falls, Managing Menopausal Symptoms]( [Platelet Stimulator OK'd for Liver Disease Patients with Scheduled Procedures]( [Drug-Eluting Balloons Come Up Short for In-Stent Restenosis]( [DES Effects Seen Extending to Users' Grandchildren]( [Digital Coaching Useful in T2D Management]( [Heart Tx Investigation; Venture Capital; Stent Retrievers; CRT Survival]( [Do You Know the Best Way to Take At-Home BP?]( [Downward Trend of PCI Patients Sticking to Antiplatelet Tx]( [Multiple Lawsuits, Multiple Deaths, $900k from Medicare]( [Men Get Short Shrift in Fertility Assessments]( [Researcher: Concussions Not Needed in CTE]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [EverydayHealth] © Copyright 2018 Everyday Health, Inc. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com [terms of use]( and [privacy policy.]( The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address:{EMAIL} [Manage my e-mail settings]( | [Unsubscribe from "Daily Headlines"](lst=Daily%20Headlines) Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.